Min Zhan
- Molecular Biology top 5%
- Cancer Research top 2%
- Cardiology and Cardiovascular Medicine top 5%
- Epidemiology top 5%
- Surgery top 10%
- Co-authors
- James SoraceFeng JiangChristopher R. deFilippiStephen L. SeligerRobert H. ChristensonJohn S. GottdienerWillem J. KopJames A. de Lemos
- Topics
- Cancer-related molecular mechanisms research (13 papers)MicroRNA in disease regulation (9 papers)Bacterial Identification and Susceptibility Testing (9 papers)
- Journals
- JAMANature CommunicationsSHILAP Revista de lepidopterología
- Partner nations
- United StatesChinaEgypt
In The Last Decade
Min Zhan
109 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Molecular Biology 1.4k
- Cancer Research 880
- Cardiology and Cardiovascular Medicine 666
- Epidemiology 509
- Surgery 501
Countries citing papers authored by Min Zhan
This map shows the geographic impact of Min Zhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Zhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Zhan more than expected).
Fields of papers citing papers by Min Zhan
This network shows the impact of papers produced by Min Zhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Zhan. The network helps show where Min Zhan may publish in the future.
Co-authorship network of co-authors of Min Zhan
This figure shows the co-authorship network connecting the top 25 collaborators of Min Zhan. A scholar is included among the top collaborators of Min Zhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Zhan. Min Zhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 3 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 4 | |
| 11 | 2 | |
| 12 | 7 | |
| 13 | 6 | |
| 14 | 28 | |
| 15 | 2 | |
| 16 | 15 | |
| 17 | 11 | |
| 18 | 18 | |
| 19 | 2 | |
| 20 | Let-7c sensitizes acquired cisplatin-resistant A549 cells by targeting ABCC2 and Bcl-XL. | 48 |
About Min Zhan
Min Zhan is a scholar working on Clinical Biochemistry, Cancer Research and Internal Medicine, having authored 114 papers that have together received 3.9k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (13 papers), MicroRNA in disease regulation (9 papers) and Bacterial Identification and Susceptibility Testing (9 papers). The work is most often cited by research in Cancer Research (880 citations), Applied Microbiology and Biotechnology (87 citations) and Clinical Biochemistry (203 citations). Min Zhan has collaborated with scholars based in United States, China and Egypt. Frequent co-authors include James Sorace, Feng Jiang, Christopher R. deFilippi, Stephen L. Seliger, Robert H. Christenson, John S. Gottdiener, Willem J. Kop, James A. de Lemos, Michael Miller and Mary‐Claire Roghmann. Their work appears in journals such as JAMA, Nature Communications and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.